Works matching IS 22107703 AND DT 2024 AND VI 46 AND IP 2

Results: 25

European Society of Clinical Pharmacy: 'Implementing and scaling sustainable clinical pharmacy'.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 355, doi. 10.1007/s11096-024-01718-w

By:

Scott, Michael;
Urbańczyk, Kamila;
Stewart, Derek

Publication type:

Article

Correction: Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy.

Published in:

2024

By:

Wirth, Francesca;
Cadogan, Cathal A.;
Fialová, Daniela;
Hazen, Ankie;
Lutters, Monika;
Paudyal, Vibhu;
Weidmann, Anita E.;
Okuyan, Betul;
Henman, Martin C.

Publication type:

Correction Notice

A cohort study comparing pharmacist activities during participation in general medical ward rounds: telehealth versus in-person during the COVID-19 pandemic.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 522, doi. 10.1007/s11096-024-01701-5

By:

Yap, Meng;
Edwards, Gail;
Gibbs, Harry;
Newnham, Harvey;
Hancock, Nicole;
Tong, Erica Y.

Publication type:

Article

Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 548, doi. 10.1007/s11096-023-01695-6

By:

Wirth, Francesca;
Cadogan, Cathal A.;
Fialová, Daniela;
Hazen, Ankie;
Lutters, Monika;
Paudyal, Vibhu;
Weidmann, Anita E.;
Okuyan, Betul;
Henman, Martin C.

Publication type:

Article

Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 488, doi. 10.1007/s11096-023-01694-7

By:

Tobaiqy, Mansour;
Elkout, Hajer

Publication type:

Article

First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 515, doi. 10.1007/s11096-023-01693-8

By:

McCall, Kenneth L.;
Doughty, Bennett J.;
Piper, Brian J.;
Naik, Heeral;
Bange, Seraphine;
Leppien, Emily E.

Publication type:

Article

Comparison of the sensitivities of pharmacotherapy-related and disease-specific quality of life measures in response to pharmacist-led pharmaceutical care for cancer outpatients: a randomised controlled trial.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 463, doi. 10.1007/s11096-023-01692-9

By:

Sakthong, Phantipa;
Soipitak, Porntip;
Winit-Watjana, Win

Publication type:

Article

Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 542, doi. 10.1007/s11096-023-01689-4

By:

Murry, Logan T.;
Desselle, Shane P.

Publication type:

Article

A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 536, doi. 10.1007/s11096-023-01687-6

By:

Takeda, Tatsuaki;
Sugimoto, Shiho;
Matsumoto, Jun;
Iwata, Naohiro;
Nakamoto, Akihiko;
Ozaki, Aya Fukuma;
Hamano, Hirofumi;
Ariyoshi, Noritaka;
Zamami, Yoshito

Publication type:

Article

Pharmacists working in residential aged care: a survey of pharmacist interest and perceived preparedness.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 506, doi. 10.1007/s11096-023-01686-7

By:

Cross, Amanda J.;
Hawthorne, Deborah;
Kouladjian O'Donnell, Lisa;
Lee, Kenneth;
Page, Amy Theresa

Publication type:

Article

Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 496, doi. 10.1007/s11096-023-01683-w

By:

Jermini, Mégane;
Fonzo-Christe, Caroline;
Blondon, Katherine;
Milaire, Christelle;
Stirnemann, Jérôme;
Bonnabry, Pascal;
Guignard, Bertrand

Publication type:

Article

Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis.

Published in:

2024

By:

Cui, Yuying;
Guo, Yingxue

Publication type:

Correction Notice

Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 451, doi. 10.1007/s11096-023-01681-y

By:

Canning, Martin Luke;
Barras, Michael;
McDougall, Ross;
Yerkovich, Stephanie;
Coombes, Ian;
Sullivan, Clair;
Whitfield, Karen

Publication type:

Article

Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 480, doi. 10.1007/s11096-023-01678-7

By:

Zhao, Yibei;
Jiang, Huiming;
Xue, Lifen;
Zhou, Mi;
Zhao, Xiaobing;
Liu, Fei;
Jiang, SongJiang;
Huang, Jing;
Meng, Long

Publication type:

Article

Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 411, doi. 10.1007/s11096-023-01677-8

By:

Castel-Branco, M. Margarida;
Lavrador, Marta;
Cabral, Ana C.;
Pinheiro, Adriana;
Fernandes, Joana;
Figueiredo, Isabel Vitória;
Fernandez-Llimos, Fernando

Publication type:

Article

Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 471, doi. 10.1007/s11096-023-01676-9

By:

Zhang, Sha;
Wang, Yidong;
Qi, Zhan;
Tong, Shanshan;
Zhu, Deqiu

Publication type:

Article

Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 429, doi. 10.1007/s11096-023-01675-w

By:

Zhang, Pei;
Zhang, Lingli;
Xu, Kai;
Lin, Yingtao;
Ma, Rui;
Zhang, Mengdie;
Li, Xin

Publication type:

Article

Screening for atrial fibrillation in care homes using pulse palpation and the AliveCor Kardia Mobile® device: a comparative cross-sectional pilot study.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 529, doi. 10.1007/s11096-023-01672-z

By:

Savickas, V.;
Stewart, A. J.;
Short, V. J.;
Mathie, A.;
Bhamra, S. K.;
Veale, E. L.;
Corlett, S. A.

Publication type:

Article

The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 368, doi. 10.1007/s11096-023-01671-0

By:

Tobaiqy, Mansour;
Helmi, Nawal;
MacLure, Katie;
Saade, Sylvia

Publication type:

Article

Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 401, doi. 10.1007/s11096-023-01669-8

By:

Kampichit, Sirinya;
Srisuriyachanchai, Warisara;
Pratipanawatr, Thongchai;
Jarernsiripornkul, Narumol

Publication type:

Article

Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 421, doi. 10.1007/s11096-023-01668-9

By:

Tsutsumi, Takezo;
Imai, Shungo;
Momo, Kenji;
Kashiwagi, Hitoshi;
Sato, Yuki;
Sugawara, Mitsuru;
Takekuma, Yoh

Publication type:

Article

Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 382, doi. 10.1007/s11096-023-01667-w

By:

Díaz Acedo, Rocío;
Galvan Banqueri, Mercedes;
Artacho Criado, Silvia;
Fernández Parra, Eva María;
Jiménez Galán, Rocío;
Gago Sánchez, Ana Isabel;
Marín Pozo, Juan Francisco;
Martínez Bautista, María José

Publication type:

Article

The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 357, doi. 10.1007/s11096-023-01666-x

By:

Alves, Carlos;
Mendes, Diogo;
Penedones, Ana;
Oliveira, Tânia;
Donato, António;
Batel-Marques, Francisco

Publication type:

Article

Communication skills-based training about medication switch encounters: pharmacy staff and patients' experiences.

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 439, doi. 10.1007/s11096-023-01664-z

By:

Schackmann, Laura;
Koster, Ellen S.;
van Dijk, Liset;
Vervloet, Marcia;
Heringa, Mette

Publication type:

Article

Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation: Prospective RandomisEd study of women of Childbearing age with gastroInteStinal Intolerance to Oral iroN (PRECISION)

Published in:

International Journal of Clinical Pharmacy, 2024, v. 46, n. 2, p. 390, doi. 10.1007/s11096-023-01640-7

By:

Ledwidge, Mark;
Ryan, Fiona;
Seoighe, Anna;
Santos-Martinez, Maria Jose;
Ryan, Cristin;
Gilmer, J. G. F.

Publication type:

Article